BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9096613)

  • 1. Transgenic expression of hepatitis C virus structural proteins in the mouse.
    Kawamura T; Furusaka A; Koziel MJ; Chung RT; Wang TC; Schmidt EV; Liang TJ
    Hepatology; 1997 Apr; 25(4):1014-21. PubMed ID: 9096613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core and E2 protein expression in transgenic mice.
    Pasquinelli C; Shoenberger JM; Chung J; Chang KM; Guidotti LG; Selby M; Berger K; Lesniewski R; Houghton M; Chisari FV
    Hepatology; 1997 Mar; 25(3):719-27. PubMed ID: 9049225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of inducible hepatitis C virus transgenic mouse lines.
    Ernst E; Schönig K; Bugert JJ; Bläker H; Pfaff E; Stremmel W; Encke J
    J Med Virol; 2007 Aug; 79(8):1103-12. PubMed ID: 17596832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establish a transgenic mice model harboring structural genes of hepatitis C virus].
    Ren JY; Cheng GX; Kong XF; Chen JQ; Zhou RJ; Lu ZM
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):501-4. PubMed ID: 16042884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice.
    Wang AG; Moon HB; Lee YH; Yu SL; Kwon HJ; Han YH; Fang W; Lee TH; Jang KL; Kim SK; Yu DY; Lee DS
    Exp Mol Med; 2004 Dec; 36(6):588-93. PubMed ID: 15675043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.
    Martinez-Donato G; Acosta-Rivero N; Morales-Grillo J; Musacchio A; Vina A; Alvarez C; Figueroa N; Guerra I; Garcia J; Varas L; Muzio V; Dueñas-Carrera S
    Biochem Biophys Res Commun; 2006 Apr; 342(2):625-31. PubMed ID: 16488393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation.
    Hiasa Y; Takahashi H; Shimizu M; Nuriya H; Tsukiyama-Kohara K; Tanaka T; Horiike N; Onji M; Kohara M
    J Med Virol; 2004 Oct; 74(2):253-61. PubMed ID: 15332274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK; Kittlesen DJ; Hahn YS
    J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus.
    Chiyo T; Sekiguchi S; Hayashi M; Tobita Y; Kanegae Y; Saito I; Kohara M
    Virus Res; 2011 Sep; 160(1-2):89-97. PubMed ID: 21645560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.
    Kamegaya Y; Hiasa Y; Zukerberg L; Fowler N; Blackard JT; Lin W; Choe WH; Schmidt EV; Chung RT
    Hepatology; 2005 Mar; 41(3):660-7. PubMed ID: 15723444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone.
    Maeda N; Watanabe M; Okamoto S; Kanai T; Yamada T; Hata J; Hozumi N; Katsume A; Nuriya H; Sandhu J; Ishii H; Kohara M; Hibi T
    Liver Int; 2004 Jun; 24(3):259-67. PubMed ID: 15189278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.
    Moradpour D; Kary P; Rice CM; Blum HE
    Hepatology; 1998 Jul; 28(1):192-201. PubMed ID: 9657112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum.
    Dries V; von Both I; Müller M; Gerken G; Schirmacher P; Odenthal M; Bartenschlager R; Drebber U; Meyer zum Büschenfeld KH; Dienes HP
    Hepatology; 1999 Jan; 29(1):223-9. PubMed ID: 9862870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
    Satoh K; Takahashi H; Matsuda C; Tanaka T; Miyasaka M; Zeniya M; Kohara M
    J Med Virol; 2010 Sep; 82(9):1545-53. PubMed ID: 20648608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.